X-153726153-A-G
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000033.4(ABCD1):āc.887A>Gā(p.Tyr296Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000096 in 1,041,684 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Consequence
NM_000033.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCD1 | NM_000033.4 | c.887A>G | p.Tyr296Cys | missense_variant | 1/10 | ENST00000218104.6 | NP_000024.2 | |
ABCD1 | XM_047441916.1 | c.887A>G | p.Tyr296Cys | missense_variant | 1/11 | XP_047297872.1 | ||
ABCD1 | XM_047441917.1 | c.887A>G | p.Tyr296Cys | missense_variant | 1/8 | XP_047297873.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 26
GnomAD4 exome AF: 9.60e-7 AC: 1AN: 1041684Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 329496
GnomAD4 genome Cov.: 26
ClinVar
Submissions by phenotype
Adrenoleukodystrophy Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Jan 01, 2016 | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PM2,PM5,PP2,PP3. This variant was detected in hemizygous state. - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 17, 2023 | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 296 of the ABCD1 protein (p.Tyr296Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with X-linked adrenoleukodystrophy (PMID: 10190819, 11748843, 15800013, 16087056, 16415970, 21068741, 22479560, 25275259, 26454440; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 193033). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCD1 protein function. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Nov 10, 2020 | - - |
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 11, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | ABCD1: PM1, PM2, PM5, PP1:Moderate, PS4:Moderate, PP3 - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Feb 17, 2022 | - - |
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2017 | The p.Y296C variant (also known as c.887A>G), located in coding exon 1 of the ABCD1 gene, results from an A to G substitution at nucleotide position 887. The tyrosine at codon 296 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration has been reported in a few individuals with adrenoleukodystrophy (Takano H et al. Arch. Neurol., 1999 Mar;56:295-300; Kemp S et al. Hum. Mutat., 2001 Dec;18:499-515; Pan H et al. Pediatr. Neurol., 2005 Aug;33:114-20; Asheuer M et al. Hum. Mol. Genet., 2005 May;14:1293-303; Sutovský S et al. Neuro Endocrinol. Lett., 2014;35:411-6; Chu SS et al. World J Pediatr, 2015 Nov;11:366-73). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at